期刊文献+

糖皮质醇激素改善慢性阻塞性肺疾病急性加重期患者肺功能的影响因素的分析 被引量:13

Impact factor analysis for improvement in lung function of patients with AECOPD treated with systemic corticosteroids
原文传递
导出
摘要 目的 对影响糖皮质醇激素改善COPD急性加重期(AECOPD)患者肺功能的可能因素进行分析,鉴定出影响FEV1改善的相关因素.方法 实验分两组,实验组AECOPD患者接受甲基泼尼松1mg· kg-1·d-1静脉滴注及其他常规治疗,对照组接受除激素以外的其他常规治疗,连续治疗1周.治疗前后对所有AECOPD患者进行诱导痰炎性细胞、炎性介质(IL-6和IL-8)、呼出气一氧化氮(FeNO)检测和肺功能的检测.利用单因素和多因素线性回归筛选FEV1改善值的影响因素.结果 AECOPD患者经激素治疗后FEV1改善值为(0.32±0.21) L[FEV1%pred改善率为(19.3±10.6)%],而对照组FEV1改善值为(0.13±0.09) L[FEV1%pred改善率为(6.8±5.1)%],两者差异有统计学意义.我们对影响激素改善FEV1值的可能因素,包括气道炎症指标(诱导痰中性粒细胞、嗜酸粒细胞、IL-6、IL-8和治疗前FeNO水平)、年龄、基础肺功能等进行分析,结果显示嗜酸粒细胞百分比、治疗前FeNO、IL-8与FEV1改善值呈正相关,相关系数分别为0.816、0.62和0.54,进一步分析提示诱导痰的嗜酸粒细胞百分比、治疗前FeNO是影响FEV1改善值的主要因素,诱导痰嗜酸粒细胞百分比比治疗前FeNO对FEV1改善值的影响意义更大.结论 嗜酸粒细胞百分比、基础FeNO可作为激素改善COPD患者FEV1的预测因素. Objective To investigated impact factor on improvement in lung function of patients with AECOPD treated with systemic corticosteroids.Methods AECOPD patients in study group were administered 40 mg/d Methyllprednisolone by intravenous injection besides other routine therapy for 1 week,AECOPD patients in control group only accepted other routine therapy.Sputum induction,lung function test,inflammatory mediators and FeNO measurement were performed in all AECOPD patients before and post treatment.Impact factors on improvement in lung function of patients with AECOPD treated with systemic corticosteroids were screened by simple linear regression or multiple regression.Results Improvement in lung function of patients with AECOPD treated with systemic were (0.32± 0.21) L,and improvement of lung function in control group were (0.13±0.09) L.This improvement was highly significant.We investigate all impact factors (including neutrophils%,eosinophils% in induced sputum,IL-6,IL-8,baseline FeNO,age and lung functions) on improvement in lung function of patients with AECOPD.The improvement in FEV1 was correlated with the percentage of eosinophils (r =0.816,P 〈0.05),baseline FeNO (r =0.62,P 〈0.05) and IL-8 (r =0.62,P 〈0.05),respectively.The future investigate show percentage of eosinophils in induced sputum and baseline FeNO are the major factors on improvement in lung function of patients with AECOPD and eosinophils% in induced sputum is the most important factor.Conclusions Our study show percentage of eosinophils in induced sputum and baseline FeNO are the major factors on improvement in lung function of patients with AECOPD treated with systemic corticosteroids.
出处 《国际呼吸杂志》 2014年第13期980-983,共4页 International Journal of Respiration
基金 广东省自然基金资助项目(s2013010016665)
关键词 糖皮质醇激素 慢性阻塞性肺疾病急性加重期 肺功能 Corticosteroid Acute exacerbation of chronic obsrtuctive pulmonary disease Lung function
  • 相关文献

参考文献9

  • 1Niewoehner DE, Erbland:ML, Deupree RH, et al. Effect of systemic glucocorticoids; on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group[J]. N Engl J Med, 1999, 340 : 1941-1947.
  • 2Pin I, Gibson PG, Kolendowicz R, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma[J]. Thorax, 1992,47 : 25-29.
  • 3Vijayan VK. Chronic obstructive pulmonary disease [J]. Indian J Med Res, 2013,137 : 251-269.
  • 4Hargreave FE, Leigh R. Induced sputum, eosinophilic bronchitis, and chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 1999,160(5 Pt 2) : $53-$57.
  • 5Lebowitz MD, Postma DS, Burrows B. Adverse effects of eosinophilia and smoking on the natural history of newly diagnosed chronic bronchitis[J]. Chest, 1995,108 : 55-61.
  • 6Cosio MG, Guerassimov A. Chronic obstructive pulmonary disease. Inflammation of small airways and lung parenchyma [J]. Am J Respir Crit Care Med,1999,160(5 Pt 2) :$21-$25.
  • 7Saetta M, Turato G, Maestrelli P, et al. Cellular and structural bases of chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med,2001,163: 1304-1309.
  • 8Antus B, Barta I, Horvath I, et al. Relationship between exhaled nitric oxide and treatment response in COPD patients with exacerbations[J]. Respirology, 2010,15 : 472-477.
  • 9Ricciardolo FL, Silvestri M, Pistorio A, et al. Determinants of exhaled nitric oxide levels (FeNO) in childhood atopic asthma:evidence for neonatal respiratory distress as a faetor associated with low FeNO levels[J]. J Asthma,2010,47:810- 816.

同被引文献133

  • 1慢性阻塞性肺疾病诊治指南(2013年修订版)[J].中国医学前沿杂志(电子版),2014,6(2):67-80. 被引量:2016
  • 2刘剑,罗志扬,张培芳.雾化吸入高剂量表面激素与全身静脉激素治疗高龄AECOPD患者的疗效对比[J].广州医学院学报,2014,42(2):39-42. 被引量:4
  • 3慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8227
  • 4中华医学会糖尿病学分会.中国2型糖尿病防治指南(2010年版)[J].中国医学前沿杂志(电子版),2011,6(3):54109.
  • 5国家卫生和计划生育委员会.关于做好2014年抗菌药物临床应用管理工作的通知[S].2014-04-14.
  • 6Eagan T M,Aukrust P, Ueland T, et al. Body composition and plas- ma levels of inflammatory biomarkers in COPD [ J ]. Eur Respir J, 2010,36 ( 5 ) : 1027-1033.
  • 7Van Scheele I, Larsson K,Pahnberg L. Budesonide enhances Toll-like receptor 2 expression in activated bronchial epithelial cells [ J ]. lnhal Toxicol,2010 ,22( 6 ) :d-9399.
  • 8Crisafulli E, Menendez R, Huerta A, et al. Systemic inilanmatory pattern of patients with community-acquired pneumonia with and without COPD [ J 1. Chest, 2013,143 (4) : 1009-1017.
  • 9McGrath-Mon'ow S A, Lauer T, Collaco J M,et al. Neonatal hyper- oxia contributes additively to cigarette smoke-induced chronic ob- structive pulmonary disease changes in adult mice [J ]. Am J Re- spir Cell Mol Biol,2011,45 ( 3 ) :610-616.
  • 10Barker B L, Haldar K, Pate1 H, et al. Association between patho- gens detected using quantitative polymerase chain reaction with airway inflammation in COPD at stable state and exacerbations [J]. Chest ,2015,147( 1 ) :46-55.

引证文献13

二级引证文献119

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部